Lee J-M, Ramos EM, LeeJ-H, et al: CAG repeat expansion in Huntingon disease determines age at onset in a fully dominant fashion. Neurology 78:690, 2012.
Lee SE, Rabinovici GD, Mayo MC, et al: Clinicopathological correlations in corticobasal degeneration. Ann Neurol 70:327, 2011.
Leenders KL, Frackowiak SJ, Lees AJ: Steele-Richardson-
Olszewski syndrome. Brain 111:615, 1988.
Lees AJ: Trauma and Parkinson’s disease. Rev Neurol 153:541, 1997.
Leigh RJ, Newman SA, Folstein SE, et al: Abnormal ocular motor control in Huntington’s disease. Neurology 33:1268, 1983.
Lennox G: Lewy body dementia. Baillieres Clin Neurol 1:653, 1993.
Leverenz J, Sumi SM: Parkinson’s disease in patients with Alzheimer’s disease. Arch Neurol 43:662, 1986.
Levy-Lahad E, Wasco W, Poorkaj P, et al: Candidate gene for the chromosome familial Alzheimer’s disease locus. Science 269:973, 1995.
LeWitt PA, Lyons KE, Pahwa R, et al: Advanced Parkinson disease treated with rotigotine transdermal system. PREFER study. Neurology 68:1262, 2007.
Li F, Harmer P, Fitzgerald K, et al: Tai chi and postural stability in patients with Parkinson’s disease. N Engl J Med 366:511, 2012.
Li G, Silverman JM, Smith CJ, et al: Age at onset and familial risk in Alzheimer’s disease. Am J Psychiatry 152:424, 1995.
Lill CM, Klein C: Parkinson’s Disease. Molecular Mechanisms Underlying Pathology. Chapter 1-The Neurogenetics of Parkinson’s Disease and Putative Links to Other Neurodegenerative Disorders, London. Academic Press, 2017, pp 1–40.
Limousin P, Krack P, Pollak P, et al: Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 339:1105, 1998.
Lin DJ, Hermann KL, Schmahmann JD: The diagnosis and natural history of multiple system atrophy, cerebellar type. Cerebellum 15:663, 2016.
Linn RT, Wolf PA, Bachman DL: Preclinical phase of Alzheimer’s disease. Arch Neurol 52:485, 1995.
Lohmann E, Periquet M, Bonifati V, et al: How much phenotypic variation can be attributed to parkin genotype? Ann Neurol 54:176, 2003.
Lomas DA, Carrell RW: Serpinopathies and the conformational dementias. Nat Rev Genet 3:759, 2002.
Louis-Bar D, van Bogaert L: Sur la dyssynergie cérébelleuse myoclonique (Hunt). Monatsschr Psychiatr Neurol 113:215, 1947.
Maddalena A, Papassotiropoulos A, Muller-Tillmanns B, et al: Biochemical diagnosis of Alzheimer disease by measuring cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42. Arch Neurol 60:1202, 2003.